Tarceva and AT-101 for Patients With Advanced Non-Small Cell Lung Cancer

NCT00934076 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study was never activated

Conditions

Carcinoma, Non Small Cell Lung

Interventions

DRUG: Tarceva plus AT-101

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]